Andrew D. Westwell - Concepedia

Author

Andrew D. Westwell

Also Known As

A D Westwell, A Westwell, A. D. WESTWELL, A. D. Westwell, A. Westwell, A.C. Westwell, A.D. Westwell, Alison Westwell, Andrew D Westwell, Andrew D. Westwell

257

Publications

7.5K

Citations

H-Index

Concepts

All Affiliations

Cardiff University University of Nottingham Zagazig University University of Wales

About

Andrew D. Westwell is an author at Cardiff University specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	40	2.6K
2	Natural Sciences	14	17	892
3	Engineering	9	9	321
4	Health Sciences	1	1	70
5	Social Sciences	1	1	10

Andrew D. Westwell

Publications

5.2K

Citations

H-Index

Page 1

	Year	Citations
Antitumor Benzothiazoles. 26. 2-(3,4-Dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a Simple Fluorinated 2-Arylbenzothiazole, Shows Potent and Selective Inhibitory Activity against Lung, Colon, and Breast Cancer Cell Lines Catriona G. Mortimer, Geoffrey Wells, Jean-Philippe Crochard, Journal of Medicinal Chemistry Medicinal ChemistrySimple FluorinatedChemoprevention StrategySelective Inhibitory ActivityNew 2-Phenylbenzothiazoles	2005	469
Antitumor Benzothiazoles. 16. Synthesis and Pharmaceutical Properties of Antitumor 2-(4-Aminophenyl)benzothiazole Amino Acid Prodrugs Ian Hutchinson, S. A. Jennings, B. Rao Vishnuvajjala, Journal of Medicinal Chemistry Medicinal ChemistryPharmaceutical ChemistryPharmaceutical ScienceBiochemistryMedicine	2001	418
Antitumor Benzothiazoles. 14. Synthesis and in Vitro Biological Properties of Fluorinated 2-(4-Aminophenyl)benzothiazoles Ian Hutchinson, Mei‐Sze Chua, Helen Browne, Journal of Medicinal Chemistry	2001	351
Synthesis and Biological Properties of Benzothiazole, Benzoxazole, and Chromen-4-one Analogues of the Potent Antitumor Agent 2-(3,4-Dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610, NSC 721648) Stefania Aiello, Geoffrey Wells, Erica L. Stone, Journal of Medicinal Chemistry	2008	333
Antitumor Benzothiazoles. 8. Synthesis, Metabolic Formation, and Biological Properties of the <i>C</i>- and <i>N</i>-Oxidation Products of Antitumor 2-(4-Aminophenyl)benzothiazoles Eiji Kashiyama, Ian Hutchinson, Mei‐Sze Chua, Journal of Medicinal Chemistry	1999	225
Cinnamaldehydes inhibit thioredoxin reductase and induce Nrf2: potential candidates for cancer therapy and chemoprevention Eng‐Hui Chew, Amrita A. Nagle, Yaochun Zhang, Free Radical Biology and Medicine Cancer TherapyReductive StressAldehyde DehydrogenasePotential CandidatesBiochemistry	2009	151
Cannabinoid receptor agonists are mitochondrial inhibitors: A unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death Andriani Athanasiou, Anna B. Clarke, Amy E. Turner, Biochemical and Biophysical Research Communications Cannabis UseUnified HypothesisMitochondrial FunctionBiochemistryMedicine	2007	151
Exploring the Structural Requirements for Inhibition of the Ubiquitin E3 Ligase Breast Cancer Associated Protein 2 (BCA2) as a Treatment for Breast Cancer Ghali Brahemi, Fathima R. Kona, Annalisa Fiasella, Journal of Medicinal Chemistry	2010	149
Antitumour benzothiazoles. Part 20: 3′-Cyano and 3′-Alkynyl-Substituted 2-(4′-Aminophenyl)benzothiazoles as new potent and selective analogues Ian Hutchinson, Tracey D. Bradshaw, Charles S. Matthews, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryDerivative (Chemistry)EngineeringAntitumour BenzothiazolesHeterocyclic	2003	123
Antitumour properties of fluorinated benzothiazole-substituted hydroxycyclohexa-2,5-dienones (‘quinols’) Cédric Lion, Charles S. Matthews, Geoffrey Wells, Bioorganic & Medicinal Chemistry Letters Antitumour PropertiesOrganic ChemistryHeterocycle ChemistryChemistryPharmacology	2006	109

Page 1